Research
Chemists at the Lawrence Livermore National Laboratory (LLNL) will spend the next month and a half preparing for an exam that will certify the laboratory to test for chemical weapons, a task it has been certified to do since 2003.
Taken in October by chemists a part of the laboratory’s... Read More »
Deltares USA and Deltares have secured $950,000 in Department of Homeland Security (DHS) Science and Technology Directorate (S&T) funds to develop a flood hazard modeling process.
The endeavor, which officials said would utilize open source data, models, and software, is in accordance with the... Read More »
Seeking greater investigations into how and where viruses and other pathogens can crossover from wildlife to people, the National Institute of Allergy and Infectious Diseases (NIAID) officially created the Centers for Research in Emerging Infectious Diseases (CREID) this week through an initial 11... Read More »
The Defense Advanced Research Projects Agency (DARPA) has gained explosives trace detection technology via the Department of Homeland Security (DHS) Science and Technology Directorate (S&T).
The Next-Generation Mass Spectrometry Explosive Trace Detector or Next-Gen Mass Spec ETD was developed in... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) is searching for new ways to deliver vaccines, and to do so, it has found four partners in research: Esperovax, Inc., the University of Connecticut, Vaxess Technologie, and Verndari, Inc.
The two options being investigated... Read More »
AbbVie is teaming up with Harvard University on a $30 million research alliance to study and develop novel therapies against emergent viral infections.
The focus of the research, which will take place at Harvard Medical School (HMS), is on viral infections caused by coronaviruses and other... Read More »
U.S. Sen. Dick Durbin (D-IL) discussed the research and approval process for COVID-19 vaccine candidates with General Gustave Perna, chief operating officer for Operation Warp Speed, a public-private partnership designed to accelerate the development of COVID-19 vaccines and treatments,
Durbin... Read More »
A phase 1 clinical trial for AZD7442, a combination monoclonal antibody treatment for COVID-19 licensed by AstraZeneca, began this week for 48 healthy participants in the United Kingdom.
Throughout the study, researchers will assess the safety, tolerability, and pharmacokinetics of the... Read More »
Bavarian Nordic released the results from its Phase 3 study of the freeze-dried formulation of its MVA-BN smallpox vaccine.
The FDA approved the liquid-frozen formulation of the vaccine in September 2019 under the name JYNNEOS. The prior Phase 2 study has shown bioequivalence between the... Read More »
Cleveland, Ohio-based University Hospitals will serve as one of 120 global clinical investigational sites to test Pfizer and BioNTech's COVID-19 vaccine.
The clinical trial would be initiated at UH Cleveland Medical Center. Dr. Robert Salata, chairman of the Department of Medicine at UH... Read More »
According to the World Health Organization (WHO) and Gavi, the Vaccine Alliance, the global COVAX initiative can now count 172 national economies and nine potential COVID-19 vaccines under its banner, seven of which have entered clinical trials.
The goal of the COVAX facility is to bring the... Read More »
Thanks to the efforts of nearly 40 companies and universities in the state of Maryland, millions of dollars have been dedicated to the research and development of vaccines, therapeutics, and tests for COVID-19, Gov. Larry Hogan announced this week.
Those efforts include millions in funding... Read More »
Northrop Grumman Corporation officials said an Integrated Battle Command System (IBCS) flight test resulted in the Army intercepting a tactical ballistic missile (TBM) and a cruise missile target.
“These two back-to-back successful test events are a testament to the commitment and partnership... Read More »
U.S. Reps. Brett Guthrie (R-KY) and Greg Walden (R-OR) finalized a report that provides recommendations for addressing a possible second wave of the coronavirus pandemic.
The third and final installment of their report – called “Second Wave Preparedness Project” -- focuses on... Read More »
Every county in the United States was scoured for COVID-19 hotspots in a recent study released by University of Utah geographers, providing localized data to track infection clusters and inform local public health policies.
Through space-time statistics, the researchers determined geographic... Read More »
Roche Pharmaceuticals is teaming up with Regeneron to develop and distribute Regeneron’s COVID-19 investigational antiviral antibody combination.
The treatment, known as REGN-COV2, is being developed as a treatment option for people already experiencing symptoms of COVID-19. It also has the... Read More »
A new, interim report from the Johns Hopkins Center for Health Security released this week showcases a path to ethical allocation and distribution of an eventual COVID-19 vaccine, meant to help facilitate those early days after it is first authorized for use.
The Interim Framework for COVID-19... Read More »
The U.S. Department of Homeland Security (DHS) Science and Technology Directorate (S&T) issued a call for candidates to submit technologies for a non-invasive febrile temperature screening of COVID-19 to be included in an upcoming market study.
All interested vendors, manufacturers, and... Read More »
Plasma Technologies of Charleston, S.C., signed an agreement with the Department of Defense’s (DOD) Joint Acquisition Task Force (JATF) to develop a process to produce higher-yielding anti-COVID-19 immune serum for scale-up and manufacturing.
A higher yield hyperimmune serum would be an... Read More »
Scientists from the University of Illinois and the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) have designed and tested a decoy protein capable of tricking SARS-CoV-2 -- the virus that causes COVID-19 -- and could potentially lead to a treatment.
Their results,... Read More »
As part of its communal effort to see a potential COVID-19 vaccine fairly manufactured and distributed throughout the world by the end of 2021, the COVAX facility has put out a call for civil society and community organizations (CSOs) to contribute.
COVAX is the brainchild of three... Read More »
GeoVax Labs is working on a collaboration to develop vaccine candidates for both the Sudan ebolavirus and Marburg virus.
The collaboration is between GeoVax, the University of Texas Medical Branch (UTMB), and Battelle Memorial Institute. The partners will utilize the suite of preclinical... Read More »
University of Washington (UW) researchers have received a $33,000 grant to develop a model using local data to potentially aid in lowering COVID-19 infections in King County.
The UW delegation is one of nine global groups receiving Society for Medical Decision Making's COVID-19 Decision Modeling... Read More »
In an effort to expand SARS-CoV-2 -- the virus that causes COVID-19 -- tests by millions per month, the United States Department of Health and Human Services (HHS) has invested $6.5 million into two commercial diagnostic laboratories: Aegis Sciences Corporation and Sonic Healthcare USA.
These... Read More »
National Security Forum (NSF) and Study of Terrorism and Responses to Terrorism (START) personnel are espousing the benefits of a recent dialogue session focusing on efforts to track drug cartels.
“An exciting development for our upcoming programs is a new collaboration NSF is building with... Read More »
A new strategy created by Novateur Ventures for treating deadly COVID-19 induced hyperinflammatory response in multiple organs was released to the public this week through the journal Frontiers in Pharmacology.
Co-authored by Ali Ardakani, founder and managing director of Novateur Ventures, and... Read More »
The global non-profit CARB-X awarded $2.91 million to German drug company Evotec SE this week, funding its efforts to develop an entirely new class of broad-spectrum antibiotics meant to treat multidrug-resistant bacterial infections.
The World Health Organization (WHO) estimates that 700,000... Read More »
Reps. Andy Barr (R-KY) and Frank Lucas (R-OK) introduced a measure they said is designed to aid universities and research institutions in protecting COVID-19 research from China and Russia cyberattacks.
The legislation would grant universities and research institutions access to cybersecurity... Read More »
With funding from the United States National Institute of Allergy and Infectious Diseases (NIAID), the COVID-19 Prevention Network (CoVPN) announced this week that it will undertake two phase 3 trials to determine the efficacy of monoclonal antibodies (mAbs) against SARS-CoV-2.
SARS-CoV-2 is the... Read More »
As Congress continues to grapple over the next COVID-19 relief package, more than two dozen senators wrote a letter to Senate leadership this week to request inclusion of $15.5 billion for the National Institutes of Health (NIH).
Whatever form the final legislation takes, they reasoned, funds... Read More »
The National Institutes of Health (NIH) is taking a new look at a severe complication of COVID-19 that affects a small percentage of children -- Multisystem Inflammatory Syndrome in Children (MIS-C) -- through the possibility of a $20 million award for research proposals.
“We urgently need... Read More »
The U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD) struck a deal with the Janssen Pharmaceuticals, which is part of Johnson & Johnson, to demonstrate large-scale manufacturing and delivery of the company's COVID-19 vaccine candidate.
As part of the agreement,... Read More »
A clinical trial dubbed I-SPY COVID enrolled its first patients last week, setting into motion plans to evaluate the efficacy of several COVID-19 therapeutics under the collaborative efforts of the COVID R&D Alliance, AbbVie, Inc., Amgen Inc., and Takeda Pharmaceutical Co. Ltd.
“I’m proud... Read More »
The National Institutes of Health (NIH) launched the Medical Imaging and Data Resource Center (MIDRC) this week, beginning a new effort to fight the COVID-19 pandemic through a mix of artificial intelligence-created tools and medical imaging.
MIDRC is a collaboration of multiple institutions,... Read More »
The Nuclear Threat Initiative’s NTI Index shows that only 47 percent of countries have a response plan in place for a cyberattack on a nuclear facility.
Further, NTI reveals that most of those nations do not have adequate regulations for cybersecurity. The NTI Index found that only 34 percent... Read More »